Loading...
Loading...
Found 1,303 Skills
Adversarial scenario analysis and threat modeling for Solidity smart contracts. Use when analyzing contracts from an attacker's perspective, identifying multi-step attack vectors, or performing threat modeling. Covers flash loan attacks, oracle manipulation, MEV/front-running, governance exploits, reentrancy scenarios, access control bypasses, economic logic exploits, and cross-contract composability risks. Triggers on tasks involving adversarial analysis, threat modeling, attack scenarios, attack vectors, exploit analysis, or red team review.
Multi-repository codebase exploration for library internals, architecture understanding, and implementation comparisons.
Perform a Cynical Review and produce a findings report. Use when the user requests a critical review of something
Regulatory variant interpretation -- GWAS association lookup, eQTL analysis, chromatin state annotation, regulatory element overlap, and trait ontology resolution. Connects GWAS Catalog, GTEx, ENCODE, RegulomeDB, OpenTargets, OLS ontology, and Ensembl regulatory features. Use when users ask about non-coding variants, GWAS hits, eQTLs, regulatory elements, enhancer/promoter variants, or trait-associated SNPs.
Audit a design proposal or diff against Exarchos's architectural invariants — event-sourcing integrity (INV-1), facade equivalence over shared dispatch core (INV-2), basileus-forward (INV-3), platform-agnosticity (INV-4), and agent-first interface design (INV-5a input ergonomics, INV-5b spec-aligned output contract, INV-5c Aspire-inspired control-plane verbs, INV-5d action discriminator pattern). Pairs with /axiom:backend-quality — this skill is project-specific (axiom is generic). Triggers: 'check invariants', 'design conformance', 'check #1118 / #1109', or /design-invariants.
Guides actuarial consulting engagements—client scoping and SOW design, stakeholder communication (CFO, risk, boards, regulators at overview level), due diligence and M&A actuarial support, reserving/pricing/capital review programs, model validation and opinion support, regulatory interaction prep, and deliverable governance (memos, exhibits, management presentations). Use when the user mentions actuarial consulting, actuarial engagement, reserve opinion, due diligence actuarial, model validation engagement, actuarial memo, SOW actuarial, regulatory actuarial, M&A reserves, or actuarial review—not deep technical modeling execution (actuary), P&C line education only (property-casualty-insurance), legal advice (commercial-counsel), or generic management consulting without actuarial lens (business-consultant).
Fan out 50+ ad variants from one hero image.
Create logo components with multiple variants (icon, wordmark, logo) and light/dark modes. Use when the user provides logo SVG files and wants to create a variant-based logo component following the Clerk pattern in the Elements project.
Variant and attribute selection on product detail pages. Use when modifying variant selectors, debugging "Add to Cart" button state, understanding option availability, or adding discount badges to options.
Adversarial code review that breaks the self-review monoculture. Use when you want a genuinely critical review of recent changes, before merging a PR, or when you suspect Claude is being too agreeable about code quality. Forces perspective shifts through hostile reviewer personas that catch blind spots the author's mental model shares with the reviewer.
Define component variants and states systematically for Figma. Use when asked to plan component variants, define states for a component, set up a Figma variant matrix, or work out what properties a component needs before building it. Produces a complete variant matrix with all properties, values, and combinations needed.
Provide comprehensive clinical interpretation of somatic mutations in cancer. Given a gene symbol + variant (e.g., EGFR L858R, BRAF V600E) and optional cancer type, performs multi-database analysis covering clinical evidence (CIViC), mutation prevalence (cBioPortal), therapeutic associations (OpenTargets, ChEMBL, FDA), resistance mechanisms, clinical trials, prognostic impact, and pathway context. Generates an evidence-graded markdown report with actionable recommendations for precision oncology. Use when oncologists, molecular tumor boards, or researchers ask about treatment options for specific cancer mutations, resistance mechanisms, or clinical trial matching.